GENFIT is a France-based late-stage biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of metabolic and inflammatory diseases.
Business Model:
Revenue: $96.9M
Employees: 51-200
Address: 885 Avenue Eugène
City: Loos
State: nord-pas-de-calais
Zip: F-59120
Country: FR
GENFIT is a France-based late-stage biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of metabolic and inflammatory diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
3/27/2019
IPO Valuation:
$769M
Ticker Symbol:
GNFT
IPO Price:
$20.32/share
Amount Raised:
$135M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2016 | Private Placement | $54.2M | 10/2016 | Private Placement | $38M | 3/2019 | IPO | $125M | 10/2017 | Private Placement | $211.1M | 12/2014 | Private Placement | $25.9M | 11/2016 | Post-IPO Equity | $49.3M | 12/2014 | Post-IPO Equity | $26.1M | 6/2008 | Venture Round | 1 | $11.1M |
Oséo Oséo Oséo Oséo |
9/1999 | Venture Round | 1 | - |
Finorpa Finorpa Finorpa Finorpa |
7/2011 | Post-IPO Equity | $7.2M | 9/1999 | Venture Round | 1 | - |
Finorpa Finorpa Finorpa Finorpa |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|